Date published: 2025-10-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

2-Iodo Adenosine (CAS 35109-88-7)

0.0(0)
Write a reviewAsk a question

Application:
2-Iodo Adenosine is an intermediate in the synthesis of isoguanosine
CAS Number:
35109-88-7
Purity:
98%
Molecular Weight:
393.14
Molecular Formula:
C10H12IN5O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

2-Iodo adenosine, a derivative of adenosine modified with an iodine atom, has garnered significant attention in biochemical and pharmacological research due to its potential as a powerful tool in studying purinergic signaling pathways and nucleoside metabolism. This compound acts as a nucleoside analog and can be phosphorylated by adenosine kinase, leading to its incorporation into nucleic acids. Furthermore, 2-iodo adenosine exhibits affinity for adenosine receptors, particularly A1 and A3 subtypes, affecting downstream signaling cascades mediated by these receptors. In cellular studies, it has been utilized to investigate the physiological roles of adenosine receptors in various biological processes, such as neurotransmission, immune modulation, and cardiovascular regulation. Additionally, 2-iodo adenosine serves as a substrate for enzymes involved in purine salvage pathways, contributing to the understanding of nucleoside metabolism and its dysregulation in pathological conditions. Moreover, researchers have explored its potential as a radioisotope-labeled tracer for positron emission tomography (PET) imaging studies, facilitating the non-invasive visualization and quantification of adenosine receptor distribution and function in living organisms. Overall, 2-iodo adenosine holds promise as a versatile research tool for elucidating purinergic signaling mechanisms, studying nucleoside metabolism, and advancing imaging techniques in biomedical research.


2-Iodo Adenosine (CAS 35109-88-7) References

  1. The utilization of purine nucleosides for nucleic acid synthesis in the rat.  |  LOWY, BA., et al. 1952. J Biol Chem. 197: 591-600. PMID: 12981089
  2. Regadenoson in the detection of coronary artery disease.  |  Buhr, C., et al. 2008. Vasc Health Risk Manag. 4: 337-40. PMID: 18561509
  3. Cladribine Analogues via O⁶-(Benzotriazolyl) Derivatives of Guanine Nucleosides.  |  Satishkumar, S., et al. 2015. Molecules. 20: 18437-63. PMID: 26473811
  4. In vitro antileukemic activity of novel adenosine derivatives bearing boron cluster modification.  |  Żołnierczyk, JD., et al. 2016. Bioorg Med Chem. 24: 5076-5087. PMID: 27600403
  5. Comparative study of inorganic, boron-rich cluster and organic, phenyl adenosine modifications: synthesis and properties.  |  Mieczkowski, A., et al. 2019. Future Med Chem. 11: 1267-1284. PMID: 31180247
  6. Synthesis and Biological Evaluation of a Novel C8-Pyrrolobenzodiazepine (PBD) Adenosine Conjugate. A Study on the Role of the PBD Ring in the Biological Activity of PBD-Conjugates.  |  Ferguson, L., et al. 2020. Molecules. 25: PMID: 32164166
  7. Chemical genetics and proteome-wide site mapping reveal cysteine MARylation by PARP-7 on immune-relevant protein targets.  |  Rodriguez, KM., et al. 2021. Elife. 10: PMID: 33475084
  8. C2-linked alkynyl poly-ethylene glycol(PEG) adenosine conjugates as water-soluble adenosine receptor agonists.  |  Ferguson, L., et al. 2023. Chem Biol Drug Des. 101: 340-349. PMID: 35993496
  9. Accumulation of cyclic adenosine monophosphate in incubated slices of brain tissue. 2. Effects of depolarizing agents, membrane stabilizers, phosphodiesterase inhibitors, and adenosine analogs.  |  Huang, M., et al. 1972. J Med Chem. 15: 462-6. PMID: 4402484
  10. Effect of purine analogues on IMP-pyrophosphorylase.  |  Hagen, C. 1973. Biochim Biophys Acta. 293: 105-10. PMID: 4734369

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

2-Iodo Adenosine, 250 mg

sc-220743
250 mg
$232.00